PCM
ROIVW

Prelude Capital Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Prelude Capital Management’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,606
Closed -$43.9K – 1593
2022
Q4 		$43.9K Hold
22,606
– – ﹤0.01% 1143
2022
Q3 		$9K Sell
22,606
-8,444
-27% -$4.49K ﹤0.01% 1328
2022
Q2 		$19K Sell
31,050
-1,712
-5% -$896 ﹤0.01% 1538
2022
Q1 		$29K Buy
+32,762
New +$41.6K ﹤0.01% 1519

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Prelude Capital Management's ROIVW Position: Q1 2023 in Review

Prelude Capital Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q1 2023, closing a stake of 22,606 shares — an estimated $43.9K sold.

Prelude Capital Management first reported a position in ROIVW in Q1 2022 and held it in 4 quarters. The position peaked at $43.9K in Q4 2022. 23 funds tracked by Wall St. Rank hold ROIVW as of Q1 2023.

  • Prelude Capital Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 22,606 Roivant Sciences Ltd. Warrant shares in Q1 2023, an estimated $43.9K.
  • Prelude Capital Management first reported a position in Roivant Sciences Ltd. Warrant in Q1 2022 and held it in 4 quarters.
  • Prelude Capital Management's Roivant Sciences Ltd. Warrant position peaked at $43.9K in Q4 2022.
  • 23 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.